Hotopf, Max

 

New Business Models for University Hospitals

University hospitals are powerhouses of medical research, the engines turning out new doctors and the places where complex diseases are treated in our societies. But what are the issues that CEOs and management teams face as they wrestle with these often-conflicting goals and the need to stay in the black financially? This panel discussion, partly […]

The power of big platforms

What are the advantages of building large international platforms in health care services? What are the synergies between different lines of business? Because of their size can big platforms achieve extra efficiencies in the rollout of digital health and AI? Confirmed speakers include: Sophie Boissard, Korian  Inaki Ereno, Bupa   francesco De Meo, Fresenius Helios […]

Regulatory and Political Risk

What has happened to regulatory and political risk in a Post-Covid world? In a detailed presentation, MWE sets out the main levels of risk in the main health care markets in EMEA and gives its analysis of how these risks are likely to develop over the next three years. This will be followed by a […]

Investing in Europe and the Middle East

What do investors think about key sectors and valuations in Europe and the Middle East? How has the pandemic changed their strategy? How will digital health change valuations and plans? Confirmed speakers include: Pascal Keutgens, CPPIB Martin Henrichs, UBS Phil Robinson, CVC Youssef Haidar, Nexus Gulf Chaired by: Max Hotopf, HBI

Investing in Health Care Services: 2021 Outlook

Six months ahead of HBI 2021, September 20-23, in London, we bring together a panel of experts to share their predictions for the sectors investing landscape in 2021, a year after the pandemic took hold in Europe. How much has the outlook for the sector changed in the first quarter of 2021? Which sub-sectors sidelined […]

How will digital impact on health care delivery and reshape health care ecosystems?

A conversation with Chinta Bhagat, Managing Partner, L Catterton Few are as well qualified as Chinta to speak on this topic. While at L Catterton, the largest global consumer focused private equity firm, he has spent time studying the acceleration of trends in digital health, using his two decades of experience in health care services. […]

State of the Region : The UK

As ever, Brexit uncertainty unnerves investors, particularly in the UK care sector. Meanwhile the London hospital market has been depressed as Arab states make other arrangements. Ireland could also be hit badly by Brexit. But there are a vast range of innovative models bubbling under in what remains Europe’s largest for-profit market for the investor. […]

Diagnostics: A new global consumer market?

Here we explore new markets for diagnostics, focusing particularly on B2C consumer markets and genetics. Panelists include: Wolf Kupatt, CEO, Amedes   Recently Amedes has developed a battery of B2C tests around areas such as the gut biome and is conducting genetic tests for consumers in Africa and Asia. What has been the feedback and what is […]

Diagnostics – Opportunities and Challenges

This session explores new ways in which lab and imaging groups are working with the public sector around the world. What models really work and why? Operator CEOs look at outsourcing, PPPs, relationships with payors and how new technology is set to change things. Panellists include: Jos Lamers, Executive Chairman, Unilabs One of the largest […]

Find Us